Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M222Revenue $M6.3Net Margin (%)-569.4Z-Score-46.5
Enterprise Value $M252EPS $-0.2Operating Margin %-440.4F-Score4
P/E(ttm))0Cash Flow Per Share $-0.2Pre-tax Margin (%)-569.4Higher ROA y-yY
Price/Book010-y EBITDA Growth Rate %0Quick Ratio0.8Cash flow > EarningsY
Price/Sales35.15-y EBITDA Growth Rate %31.1Current Ratio1.0Lower Leverage y-yN
Price/Cash Flow0y-y EBITDA Growth Rate %0ROA % (ttm)-141.7Higher Current Ratio y-yN
Dividend Yield %0Insider Buy (3m)2ROE % (ttm)0Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M150ROI % (ttm)-168.4Gross Margin Increase y-yY

Gurus Latest Trades with NAVB

Number of guru portfolios checked: 68.
No Entry found in the selected group of Gurus. You can

NAVB is held by these investors:

No Entry found in the selected group of Gurus. You can
Premium Most recent portfolio changes are included for Premium Members only!


NAVB: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
LARSON BRENT LEVP, CFO, Treas and Sec'y 2015-04-01Sell20,000$1.58-3.8 view
GOLDBERG MICHAEL MDirector 2014-11-14Buy100,000$1.0840.74 view
FORD BRENDAN ADirector 2014-11-10Buy10,000$1.0347.57 view
Nordlicht Mark10% Owner 2014-09-02Sell60,000$1.3611.76 view
Regan William J.SVP-Global Reg Affairs&Quality 2014-05-12Buy5,000$1.436.29 view
PYKETT MARK JEROMECEO 2014-05-09Buy10,000$1.3413.43 view
PYKETT MARK JEROMECEO 2014-03-10Sell120,000$1.96-22.45 view
LARSON BRENT LEVP, CFO, Treas & Secy 2014-03-10Sell41,500$1.96-22.45 view
Cope Frederick OSVP 2014-03-10Sell15,000$1.96-22.45 view
FORD BRENDAN ADirector 2013-11-08Buy20,000$1.454.83 view

Press Releases about NAVB :

    Quarterly/Annual Reports about NAVB:

    News about NAVB:

    Articles On GuruFocus.com
    Navidea Biopharmaceuticals Reports 4 Insider Trades Mar 18 2013 
    comment on NAVB Mar 16 2013 


    More From Other Websites
    Navidea Announces Lymphoseek® Presentations at Upcoming Medical Conferences Apr 15 2015
    Macrophage Therapeutics Announces Manocept™ Results in Kaposi’s Sarcoma Studies to Be Presented... Apr 15 2015
    Macrophage Therapeutics Announces Manocept™ Results in Kaposi’s Sarcoma Studies to Be Presented... Apr 15 2015
    Navidea Announces Lymphoseek® Presentations at Upcoming Medical Conferences Apr 15 2015
    NAVIDEA BIOPHARMACEUTICALS, INC. Files SEC form 8-K, Change in Directors or Principal Officers Apr 01 2015
    Should Navidea Biopharmaceuticals (NAVB) Be On Your Radar Now? - Tale of the Tape Apr 01 2015
    Navidea Biopharmaceuticals Announces Presentation of Lymphoseek® Data at Society of Surgical... Mar 25 2015
    Navidea Biopharmaceuticals Announces Presentation of Lymphoseek® Data at Society of Surgical... Mar 25 2015
    NAVIDEA BIOPHARMACEUTICALS, INC. Financials Mar 21 2015
    Macrophage Therapeutics to Expand Efforts Into CNS Diseases Mar 20 2015
    Macrophage Therapeutics to Expand Efforts Into CNS Diseases Mar 20 2015
    NAVIDEA BIOPHARMACEUTICALS, INC. Files SEC form 8-K, Other Events Mar 19 2015
    NAVIDEA BIOPHARMACEUTICALS, INC. Files SEC form 10-K, Annual Report Mar 16 2015
    Macrophage Therapeutics, a Subsidiary of Navidea Biopharmaceuticals, Executes Securities Purchase... Mar 13 2015
    Macrophage Therapeutics, a Subsidiary of Navidea Biopharmaceuticals, Executes Securities Purchase... Mar 13 2015
    NAVIDEA BIOPHARMACEUTICALS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement,... Mar 11 2015
    NAVIDEA BIOPHARMACEUTICALS, INC. Files SEC form 8-K, Results of Operations and Financial Condition,... Mar 06 2015
    CLARIFICATION of Navidea Announces Fourth Quarter and Full Year 2014 Results Mar 05 2015
    CLARIFICATION of Navidea Announces Fourth Quarter and Full Year 2014 Results Mar 05 2015
    Navidea Biopharmaceuticals Inc Earnings Call scheduled for 8:30 am ET today Mar 05 2015

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    FEEDBACK